ReviewBioactive materials2026
Adhesive bioactive materials in ocular applications: Toward smart, regenerative, and minimally invasive therapies.
Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular adhesive bioactive materials represent a paradigm shift in ophthalmic surgery and tissue repair, offering sutureless solutions with enhanced biocompatibility, reduced complications, and improved clinical outcomes. Designed to function as sealants, defect fillers, and delivery vehicles for drugs or cells, these materials must meet the stringent physiological and optical demands of the ocular environment. They are typically classified by anatomical application (ocular surface vs. fundus) and material origin (natural vs. synthetic), and rely on diverse crosslinking strategies to achieve tailored mechanical and adhesive properties. Current design approaches increasingly embrace biomimetic principles-aiming to replicate the structural and functional characteristics of native ocular tissues-to improve integration and therapeutic effectiveness. Moreover, the combination of adhesive materials with regenerative therapies such as stem cells, and exosomes extends their potential from simple structural support to active tissue regeneration. This review provides a comprehensive synthesis of ocular adhesive bioactive materials, outlines major design strategies and applications, and highlights future directions toward personalized and programmable regenerative platforms capable of addressing complex ophthalmic challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.